NCT02191241View on ClinicalTrials.gov

Pharmacokinetics of a Single Oral Dose of 1,800 mg Red Vine Leaf Extract (Antistax®)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

Red Vine Leaf Extract

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY